Research shows a strong and consistent association between pregnancy loss and type 2 diabetes (T2D), and the risk of developing T2D increases with a higher number of pregnancy losses, according to a study published in Diabetologia.
Research shows a strong and consistent association between pregnancy loss and type 2 diabetes (T2D), and the risk of developing T2D increases with a higher number of pregnancy losses, according to a study published in Diabetologia.
About 1 in 4 wanted pregnancies in the United States end in a loss, the study's authors said, with pregnancy loss defined as “the spontaneous demise of a pregnancy prior to 22 weeks of gestation.” This rate corresponds to approximately 1 million lost pregnancies in the United States every year.
According to the researchers, around 60% of pregnancy losses are due to fetal aneuploidy while the remaining 40% of euploid losses may be caused by point mutations, structural abnormalities, or other factors. Previous studies demonstrated pregnancy loss is a predictor of atherosclerotic disease and ischemic heart failure in later life.
In a nationwide case-control study, Danish researchers matched 24,774 women with T2D born between 1957 and 1997 to 247,740 controls. For each case of T2D, “10 female birth year- and education-matched controls without T2D were randomly selected from the Danish general population using an exact matching algorithm, where cases could not be used as controls.”
Although 74.5% of the case participants and 78.7% of controls never experienced a pregnancy loss, women with 1, 2, and at least 3 pregnancy losses constituted 19.1%, 4.3%, and 2.1% of the case population and 16.8%, 3.2%, and 1.3% of the controlsl.
Data revealed:
After adjusting for obesity, a case sample of 3064 was compared with 42,276 controls. Data showed women who lost pregnancies still had significantly increased ORs for T2D. “Likewise, pregnancy loss remained a significant risk factor after adjustment for gestational diabetes,” the authors said.
The study also found women never achieving pregnancy and women with pregnancy losses with a high probability of euploid losses and losses with an immunological background both exhibited an increased risk of T2D.
“The association between these predefined groups and T2D supports the theory that the association could be influenced by immunological factors (eg, low-grade inflammation or metabolic disturbances with an immune component),” the authors said. However, psychological distress related to pregnancy loss, potentially altering lifestyle habits, and increasing body mass index could also increase the risk of T2D.
“Whether metabolic conditions at the time of pregnancy loss explain the association with T2D or the association is caused by a shared aetiology need to be explored in future studies,” the authors concluded.
Reference
Egerup P, Mikkelsen AP, Kolte AM, et al. Pregnancy loss is associated with type 2 diabetes: a nationwide case-control study. Diabetologia. Published online May 20, 2020. doi:10.1007/s00125-020-05154-z
Exploring Pharmaceutical Innovations, Trust, and Access With CVS Health's CMO
July 11th 2024On this episode of Managed Care Cast, we're talking with the chief medical officer of CVS Health about recent pharmaceutical innovations, patient-provider relationships, and strategies to reduce drug costs.
Listen
How Can Employers Leverage the DPP to Improve Diabetes Rates?
February 15th 2022On this episode of Managed Care Cast, Jill Hutt, vice president of member services at the Greater Philadelphia Business Coalition on Health, explains the Coalition’s efforts to reduce diabetes rates through the Diabetes Prevention Program (DPP).
Listen
Team-Based CINEMA Program Targets SDOH and Precision Care in Diabetes
December 20th 2024Ian Neeland, MD, discusses the CINEMA program's impact on addressing social determinants of health (SDOH) in Ohio and the importance of precision risk tests to reduce cardiovascular metabolic disease risk.
Read More